This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Cameron AJ, Lomboy CT Pera M et al. Adenocarcinoma of oesophagogastric junction and Barrett’s oesophagus. Gastroenterology 1992;103(4):1241–45.
Jankowski J, Harrison R, Perry I et al. Barrett’s metaplasia. Lancet 2000;356:2079–85.
Drewitz DJ, Sampliner RE, Garewal HS. The incidence of adenocarcinoma in Barrett’s esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 1997;92:212–15.
Poynton AR, Walsh TN, O’Sullivan G, Hennessy TPJ. Carcinoma arising in familial Barrett’s esophagus. Am J Gastroenterol 1996;91:1855–6.
Jankowski J, Hopwood D, Pringle R, Wormsley K. Increased expression of EGFR in Barrett’s esophagus associated with alkaline reflux: a putative model for carcinogenesis. Am J Gastroenterol 1993;56:1480–3.
Klump B, Hsieh CJ, Holzman K et al. Hypermethylation of the CDKNZ/p16 promoter during neoplastic progression of Barrett’s esophagus. Gastroenterology 1998;115:1381–86.
Wong DJ, Barrett MT, Stoger R et al. p16/NK4a promoter is hypermethylated at a higher frequency in esophageal adenocarcinoma. Cancer Res 1997;57:2619–22.
Morales CP, Lee EL, Shay JW. In situ hybridisation for the detection of telomerase RNA in the progression from Barrett’s esophagus to esophageal adenocarcinoma. Cancer 1998;83:652–9.
Reid BJ, Haggitt RC, Rubin CE et al. Flow-cytometric and histological progression to malignancy in Barrett’s esophagus: prospective endoscopic surveillance of a cohort. Gastroenterology 1992;102:1212–19.
Richards FM, McKee SA, Rajpar MH et al. Germ-line Ecadherin gene (CDH1) mutations predispose to familial gastric and colorectal cancer. Hum Mol Genet 1999;4:607–10.
Funkhouser EM, Sharp GB. Aspirin and reduced risk of esophageal carcinoma. Cancer 1995;76:1116–19.
Thun MJ, Namboodiuri MM, Calle EE et al. Aspirin use and risk of fatal cancer. Cancer Res 1993;53:1322–27.
Edwards MJ, Gable DR, Lentsch AB et al. The rationale for oesophagectomy as the optimal therapy for Barrett’s oesophagus with high-grade dysplasia. Ann Surg 1996;223(5):585–9.
Canto MI, Setrakian S, Willis J et al. Methylene blue-directed biopsies improve detection of intestinal metaplasia and dysplasia in Barrett’s esophagus. Gatsrointest Endosc 2000;51(5):560–8.
Endlicher E, Knuechel R, Hauser T et al. Endoscopic fluorescence detection of low and high grade dysplasia in Barrett’s oesophagus using systemic or local 5-aminolaevulinic acid sensitisation Gut 2001;48:314–319.
Muto M, Hitomi Y, Ohtsu A et al. Association of aldehyde dehydrogenase 2 gene polymorphism with multiple oesophagea dysplasia in head and neck cancer patients. Gut 2000;47(2):256–61.
Itakura Y, Sasano F, Date F et al. DNA ploidy, p53 expression and cellular proliferation in normal epithelium and squamous dysplasia of non-cancerous and cancerous human oesophagi. Anticancer Res 1996;16(1):201–8.
Sanders DS, Bruton R, Darnton SJ et al. Sequential changes in cadherin-catenin expression associated with the progression and heterogeneity of primary oesophageal squamous carcinoma. Int J Cancer 1998;79(6):573–9.
Jenkins TD, Mueller A, Odze R et al. Cyclin D1 overex-pression combined with N-nitrosomethylbenzylamine increases dysplasia and cellular proliferation in murine esophageal squamous epithelium. Oncogene 1999;18(1):59–66.
Sibble A, Lambert R, Souquet JC et al. Long-term survival after PDT for esophageal cancer. Gastroenterology 1995;108:337–46.
Risk JM, Whittaker J, Fryer A et al. Tylosis oesophageal cancer mapped. Nat Genet 1994;8:319–21.
Odze R, Antonioli D, Shocket D et al. Esophageal squamous papillomas. A clinicopathologic study of 38 lesions and analysis for human papilloma virus by the polymerase chain reaction. Am J Surg Pathol 1993;17(8):803–12.
Orlowska J, Jarosz D, Gugulski A et al. Squamous cell papillomas of the esophagus: Report of 20 cases and literature review. Am J Gastroenterol 1994;89(3):319–21
Rights and permissions
Copyright information
© 2005 Springer-Verlag London Limited
About this chapter
Cite this chapter
Latchford, A., Jankowski, J.A. (2005). Premalignant Lesions of the Oesophagus: Identification to Management. In: Upper Gastrointestinal Surgery. Springer Specialist Surgery Series. Springer, London. https://doi.org/10.1007/1-84628-066-4_19
Download citation
DOI: https://doi.org/10.1007/1-84628-066-4_19
Publisher Name: Springer, London
Print ISBN: 978-1-85233-607-3
Online ISBN: 978-1-84628-066-5
eBook Packages: MedicineMedicine (R0)